90 results about "Eyes irritation" patented technology

The present invention is directed to pesticidal formulations utilizing novel alkylpolyglycoside amines as adjuvants. The pesticidal formulation need not, but may, include an additional eye irritation-reducing complex. The adjuvant is particularly useful with glyphosate (N-(phosphonomethyl)glycine) compositions. Methods for using these pesticidal formulations are also disclosed.

A light shield device (13) which is attached to light wands (30) of various diameters to filter and redirect reflected light. The shield has a planar part (13) with an attached retainer column (20) mounted in an off-center location, a see-through mirror (16) in a central location, and a reflective Fresnel lens configuration (14) at its outer perimeter. The device is formed of plastics which filter some radiation. The shield permits an operator to monitor light applications without harmful eye irritations.

The invention relates to a display brightness adjusting method and system for a virtual reality device. The display brightness adjusting system comprises a confirmation unit, an obtaining unit and an adjusting unit, wherein the confirmation unit is used for confirming that the virtual reality device is being worn; the obtaining unit is used for obtaining ambient light intensity of an external environment where the virtual reality device is placed, and therefore the display brightness of a screen of the virtual reality device can be adjusted to the ambient light intensity; the adjusting unit is use for again adjusting the display brightness with the ambient light intensity to brightness, preset in normal working conditions, of the virtual reality device in a preset time length. So the display brightness adjusting method and system for the virtual reality device can be used for adjusting the display brightness of the virtual reality device according to the ambient light intensity, eye irritations of a user can be reduced when the user uses the virtual reality device, and user experience can be improved.

The invention relates to eye mask for healthcare product for eyes and the preparation method, which is characterized in that: the eye mask comprises non woven fabric adding medical solution; following raw material of weight are added into each 1000 ml of medical liquor: ginsenoside 2 to 3g, lucid ganoderma and spores powder 0.08 to 0.12g, pearl 2 to 3g, puerarin 0.4 to 0.6g, wild chrysanthemum flower 18 to 25g, mint 15 to 18g, musk 0.06 to 0.08g and borneol 0.2 to 0.6g. Through test of Health Supervision Test Center of Jilin Province: acute toxicity experiment of mouse skin shows that the eye mask does not have toxin; acute eye irritation experiment of rabbit shows the does not have irritation; test of 40 tested volunteers with fatigable eyesight shows that the eye mask has the function of relieving fatigue of eyesight.

Agricultural compositions and/or tank mix adjuvants, which exhibit enhanced performance properties such as reduced eye irritation, reduced fish toxicity, and improved compatibility with other tank mixed pesticides and/or adjuvants while maintaining typical pesticidal performance characteristics containing at least one amine ethoxylate and glycerol.

The disclosure relates to a method, apparatus and device for controlling illuminating lamps. The method comprises following steps: when illuminating lamps of a terminal are in an on-state, detecting the luminance value in the current environment of the terminal in real time or regularly; obtaining a first illuminating luminance value within an illuminating luminance range matching the luminance value of the current environment according to the corresponding relation between preset environment luminance values and the illuminating luminance range; controlling the illuminating lamps to illuminate at the first illuminating luminance value. By means of the method, no matter how high or how low of the luminance value of the current environment is, the terminal can always control the illuminating lamps to illuminate at an illuminating luminance value which is suitable for the terminal in the current environment. Compared with correlative technologies of illuminating with strong illumination intensity in dark environment, by means of the method, eye irritation due to strong illumination in dark environment can be avoided so that damage to users can be reduced.

Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.

The present invention generally relates to herbicidal compositions comprising a herbicide, an etheramine alkoxylate surfactant, an alkylamine alkoxylate surfactant having a high degree of alkoxylation and compatibilizer comprising, in some embodiments, an alkylamine alkoxylate surfactant having a low degree of alkoxylation or an alkylpolyglucoside surfactant. The herbicidal compositions are herbicidally efficacious and cause low eye irritation and low crop injury.

An animal deterrent device and method of using the device is disclosed. The device consists of a dazzler laser that produces eye irritation in an animal which results in the animal turning away from the user of the device. The device incorporates a diverging lens such that the dazzler laser produces a beam with a wide spread that makes it is easy to shine the beam on a potentially dangerous animal, but where the light is of sufficient intensity to irritate the animal's eyes.

The invention discloses a makeup removing lotion gel, which is prepared from the following ingredients: 4.0-8.0 parts by weight of PEG (polyethylene glycol)-6 caprylic acid/capric triglyceride, 0.8-1.0 parts by weight of water-soluble olive oil, 0.1-0.5 part by weight of PEG/PPG (polypropylene glycol)-25/30 copolymer, 3.0-8.0 parts by weight of polyatomic alcohol compound, 0.3-1.0 part by weight of squalane, 0.15-0.5 part by weigh of acrylic resin and 80-88 parts by weight of water. The preparation method for the makeup removing lotion gel comprises the following steps: forming a ternary decontamination micro-capsule covering body by a PEG-6 caprylic acid/capric triglyceride, water-soluble olive oil and PEG/PPG-25/30 copolymer; then, preparing microemulsion with squalane; using an acrylic resin stabilization system to form the semi-transparent makeup removing lotion gel. The makeup removing lotion gel has the advantages of high makeup removing ability, high safety, small irritation to eyes and easiness in washing, and skin is moisturized and moistened and is not oily after the makeup removing lotion gel is used.

The invention provides a water soluble granule of chlorfenapyr. It is made from (by wt%) chlorfenapyr 0.5-50%, emulsifier 1-30%, dispersing agent 1-10%, wetting agent 1-5%, binder 2-4%, stabilizer 1-3% and the rest is filling material. The invention comprises no or small toxic and inflammable aromatic hydrocarbon solvent, therefore the risk of burning and exploding during manufacture, storage and transportation can be reduced. Its advantages include no poison and pollution, no unpleasant odor, low eye irritation, higher safety for producers, transporters and users.

The invention discloses an antipruritic and anti-allergic baby washing and protecting preparation and an application thereof. The antipruritic and anti-allergic baby washing and protecting preparations comprises a wild chrysanthemum flower extract, a dandelion extract, a milkvetch root extract, and a bitter apricot seed extract. The antipruritic and anti-allergic baby washing and protecting preparation contains mild and natural plant extracts, the addition of irritant substances is avoided from the raw materials, the irritation of the product is reduced, and the relatively good experience sense, and relatively strong anti-allergenicity and antipruritic performance are realized through the synergistic compatibility effects of the specific components. The patch test results show that the washing and protecting preparation is a negative result, and does not have irritation to the skin, the eye irritation test results show a NC value of less than or equal to 2, the washing and protecting preparation is the stress irritation, namely, is damage-free irritation, has no eye irritation, and is safe and mild. In addition, a foam volume of the product can reach 770 mL, the time of discharging50 mL of a liquid by foam can reach 11.8 s, the foaming ability is strong, the foam stability is good, and thereby the washing and protecting preparation can be widely used in the preparation of infants and young children products.

The present invention relates to a dyeing composition. More particularly, the present invention provides a dyeing composition comprising an ether-based nonionic surfactant, an ether-based oil and alcohol. Preferably, the ether-based nonionic surfactant, the ether-based oil and the alcohol have the same number of carbon atoms. The dyeing composition according to the present invention comprises the ether-based nonionic surfactant, the ether-based oil and the alcohol, forms a multi-lamellar liquid crystal structure, allows for ease of material application and maintains excellent color formation, and particularly, mitigates pungent smell, eye irritation and the like.

The invention discloses eye irritation-free cleansing bubble with functions of makeup removal and skin care, and a preparation method of the cleansing bubble. The cleansing bubble is mainly prepared from the following components: water, glycerin, sodium lauroyl oat amino acids, potassium cocoyl glycinate, ammonium lauryl sulfate, cocamide MEA, an acrylate/vinyl neodecanoate cross-linked polymer, cocamidopropyl betaine, sodium PEG-7 olive oil carboxylate, a hamamelis virginiana extract, an iris florentina root extract, a rosemary extract, a licorice root extract, dipotassium glycyrrhizinate, sodium hyaluronate, 1, 2-hexanediol, beta-glucan, disodium ethylene diamine tetraacetic acid (EDTA), fullerene, leuconostoc/radish root fermention product filtrate and neroli oil. The preparation methodcomprises the following preparation processes: weighing the raw material according to a proportion, heating for dissolving, mixing and stirring, cooling, detecting, filling, testing, and the like. The prepared cleansing bubble solves the problems that a great deal of active agent is added into the traditional cleanser, thus causing the skin to lose vitality, and after being used, oily makeup remover can not be cleaned at a time, thus easily enabling the skin pores to become larger and easily causing skin allergy.

The present invention is directed to a pesticidal composition of a water-soluble pesticide and processes for its manufacture. More specifically, the invention relates to a soluble granule (SG) pesticidal formulation comprising a water-soluble pesticide and a water-soluble filler. The present invention provides a pesticidal formulation with efficacy equal to the corresponding liquid formulation, yet with improved handler safety, such as lower eye irritation.

The invention belongs to the field of pharmaceutical pharmacy, and relates to a vitamin A palmitate eye drop, a preparation method and a use thereof. Specifically the eye drop contains 0.01-0.2% (w/w) of vitamin A palmitate adopted as a main drug, 0.01-5.0% (w/w) of a solubilizing agent and 0.01-10.0% (w/w) of a co-solvent. According to the present invention, the assisted solubilizing manner is adopted so as to solve problems of solubility and stability of vitamin A palmitate in water; and the eye drop is a light yellow transparent solution, has a characteristic of low eye irritation, and is suitable for eyes.

The invention provides a blood pressure-regulating and sleep-promoting pillow core belonging to the field of medical health care products. The pillow core uses chrysanthemum, hemlock parsley, cortex moutan, kendir, bupleurum herb, bamboo leaf and lotus leaf as raw materials, and is manufactured in the following steps: mixing the raw materials based on a certain ratio, crushing and encapsulating. Clinical experiment indicates that the long-term use of the pillow core can effectively improve the sleep quality and the sleep effect, people can not suffer from xerostomia and eye irritation and can keep a cool head, and the pillow core also achieves the effect of regulating the blood pressure. The pillow core is convenient to use, and people can persist in everyday treatment and regulation without paying any effort, thereby saving a lot of trouble and avoiding the pain caused by taking medicine.

The insecticide composition of the present invention is characterized in that it contains (1) a chloronicotinoid compound as an insecticidal active ingredient, (2) as an organic solvent, dimethylsulfoxide and dimethylacetamide or γ-butyrolactone mixed solvent, or 3 kinds of mixed solvents to which N-methylpyrrolidone is further added, and (3) castor oil-based surfactants or propylene oxide/ethylene oxide block polymer-based surfactants It has weak irritation to the eyes, is difficult to precipitate crystals even at low temperature, can be uniformly dissolved in water, and exhibits excellent biological activity.

An adjuvant composition for pesticide formulations which exhibits reduced eye irritancy is comprised of a polyoxyalkylene aliphatic amine containing at least about 2 moles of an alkylene oxide group and an eye irritation reducing compound which simultaneously reduces the eye irritation caused by the polyoxyalkylene aliphatic amine and which complexes with metal ions such as calcium and iron which may be present in an aqueous solution of the adjuvant and a pesticide or a plant growth regulator. The eye irritation reducing compound is a carboxylic acid that is capable of complexing with or forming chelates with metal ions in aqueous solution while simultaneously reducing the eye irritation caused by the polyoxyalkylene aliphatic amine. The adjuvant also contains a mixture of polyhydric alcohols and, optionally, a defoamer. The adjuvant is particularly in N-phosphonomethylglycine (glyphosate) herbicidal formulations.

The invention relates to the technical field of cosmetics with the IPC classification number of A61K8/92, in particular to soothing and anti-inflammatory cleansing oil and a preparation method thereof. The cleansing oil is prepared from the following raw materials: 2wt%-10wt% of effective components and 90wt%-98wt% of main components, wherein the effective components comprise a water-containing emulsifier and a water-soluble active matter; the weight ratio of the water-containing emulsifier to the water-soluble active matter is 1: (0.5-5). According to the cleansing oil disclosed by the invention, water-soluble active substances can be added, and the addition amount of the water-soluble active substances is higher than that of the active substances in the prior art, so that the cleansing effect of the cleansing oil cannot be influenced when the higher active substances are added, the cleansing oil can be normally used, and after water is added for cleansing, the eye irritation is obviously improved.

The invention relates to a medicine composition and a preparation method thereof, in particular to an ophthalmic medicine composition and a preparation method thereof. The ophthalmic medicine composition comprises an antivirus medicine with 0.005 to 5.0 weight percent of effective dose, DXM with 0.0005 to 0.1 weight percent of the effective dose and medicinal additive. The medicine composition used for curing herpes simplex keratitis can greatly enhance the recovery process of the herpes simples keratitis and deep solid herpes simples keratitis, effectively improve eye irritation symptoms, shorten healing time and reduce the recurrence rate of the herpes simples keratitis.

The present invention relates to a novel application of perspiration absorption from the face of a user wearing a virtual reality Head Mounted Display (HMD). More particularly, the invention relates to the use of perspiration absorbing materials ergonomically fitted to the user's face to provide a sanitary shield between the user's face and the worn virtual reality HMD. Due to the invention's ergonomic design, perspiration is prevented from entering the user's eyes preventing eye irritation while wearing a virtual reality HMD during vigorous usage. Since the face pad is designed to conform to a general user's face, it is not specific to any make or model of HMD and thus can be used with HMD's from any manufacturer.

The invention relates to a TCM (traditional Chinese medicine) tea bag for myopia and a preparation method thereof. The TCM tea bag is made from, by weight, for preparing 5kg of the TCM tea bag, 150g of prepared rehmannia root, 150g of mulberry leaf, 150g of chrysanthemum, 125g of white peony root, 130g of wolfberry fruit, 125g of Chinese yam, 125g of immature orange fruit, 125g of rice-grain sprout, 100g of cicada slough, 100g of rhizome of oriental water plantain, 100g of mulberry, and 3600g of Pu'er tea. The preparation method includes: according to the precise weight ratio, boiling the above materials except the Pu'er tea, filtering residue, adding the Pu'er tea to soak for two hours, performing high temperature sterilization and air-drying and other steps. The TCM tea bag is capable of treating the myopia, astigmatism, ocular fundus lesions, anorexia, abdominal distension, dryness of eyes, eye irritation, eyestrain and the like. According to more than 60 years of clinical verification, compared with the conventional similar products, the TCM tea bag has more significant and better therapeutic effects.